BRCA1 and breast carcinoma: Therefore, telomerase inhibition in the primary infiltrating ductal carcinoma cell line with a BRCA1 gene mutation, HCC1937, will be compared to a breast cancer cell line without detectible BRCA1 gene mutations, HCC1599.